[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Research Letter
February 2017

Analysis of Trends in US Melanoma Incidence and Mortality

Author Affiliations
  • 1National Society for Cutaneous Medicine, New York, New York
  • 2OhioHealth, Athens, Ohio
  • 3Icahn School of Medicine at Mt. Sinai, New York, New York
  • 4Ronald O. Perelman Department of Dermatology, NYU School of Medicine, New York, New York
JAMA Dermatol. 2017;153(2):225-226. doi:10.1001/jamadermatol.2016.4512

The incidence of and mortality from invasive melanoma in the United States has risen steadily for at least the past 2 decades.1 Similar trends are being seen worldwide despite numerous efforts to enhance primary prevention and early detection, and these increasing rates are having an impact on the public health and economic burden of disease. In 2009, we reported on the status of US melanoma incidence at that time.2 The purpose of this study was to provide updated information on trends in melanoma incidence and mortality that will help to elucidate the current state of this cancer in the United States.